Homepage
Medication Guide
How to Purchase Cobimetinib (Cotellic)
Cobimetinib (Cotellic) is an important kinase inhibitor primarily used for the treatment of certain types of melanoma and thyroid-like tumors. As a prescription medication, its purchase and use are su...
503
Wednesday, November 12th, 2025, 10:49
What Are the Side Effects of Epclusa (Sofosbuvir/Velpatasvir)?
Epclusa (sofosbuvir/velpatasvir) is the world’s first antiviral medication covering all 6 genotypes of hepatitis C virus (HCV). Its outstanding efficacy has transformed the treatment landscape for hep...
501
Wednesday, November 12th, 2025, 10:40
Precautions for Using Epclusa (Sofosbuvir/Velpatasvir)
Epclusa (sofosbuvir/velpatasvir) is a curative therapy for pan-genotypic chronic hepatitis C, whose efficacy has been widely verified in clinical practice. As a potent antiviral medication, it has spe...
504
Wednesday, November 12th, 2025, 10:34
Indications of Epclusa (Sofosbuvir/Velpatasvir)
Epclusa (sofosbuvir/velpatasvir) is an important anti-hepatitis C virus (HCV) medication developed by Gilead Sciences, Inc. (U.S.), providing comprehensive treatment options for patients with chronic ...
501
Wednesday, November 12th, 2025, 10:01
How to Use Encorafenib (Braftovi)
Encorafenib (Braftovi) is a kinase inhibitor that was first approved in the United States in 2018 for the treatment of advanced malignant tumors harboring specific BRAF gene mutations.How to Use Encor...
501
Wednesday, November 12th, 2025, 09:52
How to Purchase Epclusa (Sofosbuvir/Velpatasvir)
Epclusa (sofosbuvir/velpatasvir) is a crucial medication for the treatment of chronic hepatitis C. Proper purchasing methods and the ability to identify genuine vs. counterfeit products are of great i...
501
Wednesday, November 12th, 2025, 09:49
Indications of Encorafenib (Braftovi)
Encorafenib (Braftovi) is an oral kinase inhibitor that first received approval for marketing from the U.S. Food and Drug Administration (FDA) in 2018. Specifically designed to treat malignant tumors ...
503
Wednesday, November 12th, 2025, 09:33
How to Purchase Encorafenib (Braftovi)
Encorafenib (Braftovi) is an important kinase inhibitor drug used for the treatment of unresectable or metastatic melanoma, metastatic colorectal cancer, and metastatic non-small cell lung cancer with...
503
Tuesday, November 11th, 2025, 11:56
What Are the Side Effects of Trabectedin (Yondelis)?
Trabectedin (Yondelis) is an alkylating agent approved by the U.S. FDA in 2015 for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have previously received ...
504
Tuesday, November 11th, 2025, 11:43
Precautions for Using Trabectedin (Yondelis)
Trabectedin (Yondelis) is a new type of alkylating agent drug. Approved for marketing in the United States in 2015, it is specifically indicated for the treatment of patients with unresectable or meta...
504
Tuesday, November 11th, 2025, 11:37
38 / 185
1842 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved